Feb 25,2019

Insulet Reports Fourth Quarter 2018 Revenue of $164.9 Million, Up 26% Year-Over-Year, and Full Year 2018 Revenue of $563.8 Million, Up 22%

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months and full year ended December 31, 2018.

View Analyst & Ambassador Comments
Go to original news
Feb 25,2019

Medtronic Wraps Up Scientific Data Presentations at the Advanced Technologies and Treatments for Diabetes International Conference

At this year's conference, the Diabetes Group at Medtronic presented a range of scientific data focusing on the company's latest MiniMed(TM) 670G system and its exclusive SmartGuard(TM) technology, including new pediatric data and the importance of Time in Range, defined as the percentage of time people with diabetes spend between the glucose range of 70-180 mg/dL (3.9-10 mmol/L).

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 25,2019

Diabetes management transformed with Quin's AI-powered app in Industrial Strategy Challenge

The Industrial Strategy Challenge funding will allow Quin to expand the app’s capabilities and address regulatory needs. As a result, the app could significantly reduce the cognitive and psychological load of the user by taking on more of the decisions they have to make.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 25,2019

ABBOTT TO PRESENT AT BARCLAYS GLOBAL HEALTHCARE CONFERENCE

Abbott will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019. Brian Yoor, executive vice president of finance and chief financial officer, will present at 1:05 p.m. Central time.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Feb 26,2019

Tandem Diabetes Care Reports 2018 Financial Results and 2019 Financial Guidance

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2018 and financial guidance for the year ending December 31, 2019. For the fourth quarter of 2018, total pump shipments of 16,168 included 3,233 pumps for the launch of international operations to select geographies outside of the United States. International sales of $7.1 million represent approximately 9 percent of total sales.

View Analyst & Ambassador Comments
Go to original news
Feb 26,2019

Tandem Diabetes Care Announces Succession Plan for Chief Executive Officer and Board of Directors

After nearly 12 years of service as Tandem’s President and CEO, Kim D. Blickenstaff will transition to a newly-created position of Executive Chairman of the Board of Directors. John F. Sheridan will succeed Mr. Blickenstaff, assuming the role of President and CEO effective March 1, 2019. Mr. Sheridan has served as the Company’s Executive Vice President and Chief Operating Officer since April 2013.

View Analyst & Ambassador Comments
Go to original news
Feb 26,2019

Virta Health Trial Demonstrates Improvement in Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

Virta Health, the first company with a treatment to safely and sustainably reverse type 2 diabetes (T2D) without the use of medications or surgery, today announced the publication of new peer-reviewed research in BMJOpen. This most recent publication found significant improvement in non-invasive scores for non-alcoholic fatty liver disease (NAFLD) and its more severe variant, non-alcoholic steatohepatitis (NASH) in patients living with type 2 diabetes who completed one year of the Virta Treatment.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Mar 12,2019

Rimidi Partners with Cellular Scale Company, Yields Promising Results for Heart Failure Management

Rimidi has partnered with BodyTrace, a cellular technology company, to provide cellular-enabled scales to heart failure patients who are remotely monitored by their clinicians using Rimidi’s software platform.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Mar 05,2019

Eversense CGM to integrate with Glooko

This morning Senseonics, an implantable glucose sensor company, announced that data from its Eversense continuous glucose monitor will be integrated into the Glooko diabetes management platform.

COLLABORATION PARTNERSHIP

#connected device

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 06,2019

Fitbit expands upon health, wellness partnerships, announces expanded support for Solera DPPs

Fitbit’s busy morning may have been headlined by news of its latest consumer devices, but lately the wearables company has also had plenty to say on its inroads with health plans, clinical researchers and large employers. In fact, the company devoted a substantial portion of its press event yesterday to its ever-growing health services operations and a new deal involving Solera Health’s integrated digital diabetes prevention plans (DPPs).

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES